vs

Side-by-side financial comparison of Firefly Aerospace Inc. (FLY) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

Firefly Aerospace Inc. is the larger business by last-quarter revenue ($30.8M vs $19.6M, roughly 1.6× STANDARD BIOTOOLS INC.). STANDARD BIOTOOLS INC. runs the higher net margin — -177.4% vs -433.5%, a 256.1% gap on every dollar of revenue. On growth, Firefly Aerospace Inc. posted the faster year-over-year revenue change (37.6% vs -11.5%). STANDARD BIOTOOLS INC. produced more free cash flow last quarter ($-23.1M vs $-62.0M).

Firefly Aerospace, Inc. (Firefly) is an American aerospace firm based in Cedar Park, Texas. Firefly develops small- and medium-lift launch vehicles for commercial launches to orbit. Firefly's stated purpose is to increase access to space, similar to other private spaceflight companies.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

FLY vs LAB — Head-to-Head

Bigger by revenue
FLY
FLY
1.6× larger
FLY
$30.8M
$19.6M
LAB
Growing faster (revenue YoY)
FLY
FLY
+49.1% gap
FLY
37.6%
-11.5%
LAB
Higher net margin
LAB
LAB
256.1% more per $
LAB
-177.4%
-433.5%
FLY
More free cash flow
LAB
LAB
$38.9M more FCF
LAB
$-23.1M
$-62.0M
FLY

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
FLY
FLY
LAB
LAB
Revenue
$30.8M
$19.6M
Net Profit
$-133.4M
$-34.7M
Gross Margin
27.6%
48.5%
Operating Margin
-202.1%
-168.5%
Net Margin
-433.5%
-177.4%
Revenue YoY
37.6%
-11.5%
Net Profit YoY
-227.1%
-28.8%
EPS (diluted)
$-1.50
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLY
FLY
LAB
LAB
Q3 25
$30.8M
$19.6M
Q2 25
$15.5M
$21.8M
Q1 25
$40.8M
Q3 24
$22.4M
$22.1M
Q2 24
$21.1M
$22.5M
Q1 24
$45.5M
Q4 23
$28.2M
Q3 23
$25.4M
Net Profit
FLY
FLY
LAB
LAB
Q3 25
$-133.4M
$-34.7M
Q2 25
$-63.8M
$-33.5M
Q1 25
$-26.0M
Q3 24
$-40.8M
$-26.9M
Q2 24
$-53.5M
$-45.7M
Q1 24
$-32.2M
Q4 23
$-19.8M
Q3 23
$-21.0M
Gross Margin
FLY
FLY
LAB
LAB
Q3 25
27.6%
48.5%
Q2 25
25.7%
48.8%
Q1 25
48.4%
Q3 24
34.7%
54.9%
Q2 24
14.0%
46.1%
Q1 24
53.1%
Q4 23
47.6%
Q3 23
44.0%
Operating Margin
FLY
FLY
LAB
LAB
Q3 25
-202.1%
-168.5%
Q2 25
-349.5%
-118.1%
Q1 25
-80.8%
Q3 24
-152.9%
-120.9%
Q2 24
-232.1%
-134.5%
Q1 24
-132.2%
Q4 23
-75.9%
Q3 23
-83.5%
Net Margin
FLY
FLY
LAB
LAB
Q3 25
-433.5%
-177.4%
Q2 25
-410.2%
-153.7%
Q1 25
-63.8%
Q3 24
-182.3%
-122.0%
Q2 24
-253.7%
-203.3%
Q1 24
-70.6%
Q4 23
-70.2%
Q3 23
-82.8%
EPS (diluted)
FLY
FLY
LAB
LAB
Q3 25
$-1.50
$-0.09
Q2 25
$-5.78
$-0.09
Q1 25
$-0.07
Q3 24
$-3.57
$-0.07
Q2 24
$-4.60
$-0.12
Q1 24
$-0.27
Q4 23
$-0.24
Q3 23
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLY
FLY
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$995.2M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$948.8M
$399.7M
Total Assets
$1.3B
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLY
FLY
LAB
LAB
Q3 25
$995.2M
$129.4M
Q2 25
$205.3M
$158.6M
Q1 25
$150.9M
Q3 24
$26.4M
$210.6M
Q2 24
$21.9M
$269.8M
Q1 24
$287.1M
Q4 23
$51.7M
Q3 23
$79.7M
Total Debt
FLY
FLY
LAB
LAB
Q3 25
Q2 25
$136.1M
Q1 25
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Q4 23
$63.5M
Q3 23
$64.6M
Stockholders' Equity
FLY
FLY
LAB
LAB
Q3 25
$948.8M
$399.7M
Q2 25
$-918.0M
$424.5M
Q1 25
$454.6M
Q3 24
$-665.5M
$489.3M
Q2 24
$-620.0M
$510.3M
Q1 24
$577.3M
Q4 23
$-148.1M
Q3 23
$-131.7M
Total Assets
FLY
FLY
LAB
LAB
Q3 25
$1.3B
$539.6M
Q2 25
$466.8M
$557.0M
Q1 25
$579.6M
Q3 24
$681.5M
Q2 24
$708.7M
Q1 24
$777.7M
Q4 23
$323.1M
Q3 23
$339.3M
Debt / Equity
FLY
FLY
LAB
LAB
Q3 25
Q2 25
Q1 25
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×
Q4 23
Q3 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLY
FLY
LAB
LAB
Operating Cash FlowLast quarter
$-53.0M
$-22.2M
Free Cash FlowOCF − Capex
$-62.0M
$-23.1M
FCF MarginFCF / Revenue
-201.3%
-118.1%
Capex IntensityCapex / Revenue
29.0%
4.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLY
FLY
LAB
LAB
Q3 25
$-53.0M
$-22.2M
Q2 25
$-20.7M
Q1 25
$-30.3M
Q3 24
$-27.9M
Q2 24
$-39.0M
Q1 24
$-62.5M
Q4 23
$-14.1M
Q3 23
$-11.4M
Free Cash Flow
FLY
FLY
LAB
LAB
Q3 25
$-62.0M
$-23.1M
Q2 25
$-22.6M
Q1 25
$-35.3M
Q3 24
$-30.1M
Q2 24
$-41.0M
Q1 24
$-63.3M
Q4 23
$-14.1M
Q3 23
$-12.3M
FCF Margin
FLY
FLY
LAB
LAB
Q3 25
-201.3%
-118.1%
Q2 25
-103.6%
Q1 25
-86.6%
Q3 24
-136.4%
Q2 24
-182.2%
Q1 24
-138.9%
Q4 23
-50.2%
Q3 23
-48.6%
Capex Intensity
FLY
FLY
LAB
LAB
Q3 25
29.0%
4.5%
Q2 25
8.7%
Q1 25
12.4%
Q3 24
10.2%
Q2 24
8.6%
Q1 24
1.7%
Q4 23
0.3%
Q3 23
3.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLY
FLY

Spacecraft Solutions Revenue$21.4M69%
Launch Revenue$9.4M31%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons